ConductScience.org, home

Paper · 69006

Cytotoxic T cells distinguish between trinitrophenyl- and dinitrophenyl-modified syngeneic cells.

Forman J. J Exp Med, 1977. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cytotoxic T cells distinguish between trinitrophenyl- and dinitrophenyl-modified syngeneic cells. Papers, record 69006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/69006

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cytotoxic T cells distinguish between trinitrophenyl- and dinitrophenyl-modified syngeneic cells.
PubMed
Journal
J Exp Med
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2019-05-08
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Forman JJ

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DinitrobenzenesMajor topic
EpitopesMajor topic
NitrobenzenesMajor topic
T-LymphocytesMajor topic
TrinitrobenzenesMajor topic
Animals
Cytotoxicity Tests, Immunologic
Haptens
In Vitro Techniques
Mice
Spleen

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,079,848On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.J Exp Med1975https://conductscience.org/library/papers/1079848PubMed
21,087,327Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.J Exp Med1976https://conductscience.org/library/papers/1087327PubMed
311,993,330Induction of T and B cell immunity by anti-idiotypic antibody.Eur J Immunol1975https://conductscience.org/library/papers/11993330PubMed
413,897,619Delayed hypersensitivity to hapten-protein conjugates. I. The effect of carrier protein and site of attachment to hapten.J Exp Med1962https://conductscience.org/library/papers/13897619PubMed
5233,899Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors.J Exp Med1977https://conductscience.org/library/papers/233899PubMed
64,108,424Functional specificity of antigen-binding receptors of lymphocytes.Transplant Rev1970https://conductscience.org/library/papers/4108424PubMed
74,126,771Overlap stimulation of primary and secondary B cells by cross-reacting determinants.J Exp Med1973https://conductscience.org/library/papers/4126771PubMed
846,185Antigen recognition in delayed-type hypersensitivity.Cell Immunol1975https://conductscience.org/library/papers/46185PubMed
95,124,960Mediators produced by sensitized lymphocytes.Fed Proc1971https://conductscience.org/library/papers/5124960PubMed
1052,182Specificity of cell-mediated lympholysis for public and private H-2 determinants.Scand J Immunol1975https://conductscience.org/library/papers/52182PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
14,627,361Specific CTL activity of CD8+ TCR Vbeta14+ T cell in mouse 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis.Dig Dis Sci2003https://conductscience.org/library/papers/14627361PubMed
316,856In vitro anamnestic immune responses and modulating factors.Mol Cell Biochem1979https://conductscience.org/library/papers/316856PubMed
311,817Specificity of cytotoxicity T cells directed to influenza virus hemagglutinin.J Exp Med1979https://conductscience.org/library/papers/311817PubMed
91,655Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.J Exp Med1979https://conductscience.org/library/papers/91655PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/69006

GET https://conductscience.org/api/papers/v1/69006/authors